000 01573nam  2200361zi 4500
0019.888429
003CaOODSP
00520221107172004
006m     o  d f      
007cr |||||||||||
008200622t20202020onc     ob   f00| 0 eng d
020 |a9780660352978
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-269/2020E-PDF
24500|aResearch priorities for COVID-19 vaccines to support public health decisions.
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2020.
264 4|c©2020
300 |a1 online resource (15 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Priorités de recherche pour les vaccins COVID-19 du CCNI à l'appui des décisions de santé publique.
500 |a"An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)."
500 |a"Advance copy."
500 |a"July 2020."
504 |aIncludes bibliographical references (page 14).
650 0|aCOVID-19 (Disease)|xVaccination|zCanada.
650 0|aViral vaccines|zCanada|xTesting.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tPriorités de recherche pour les vaccins contre la COVID-19 à l'appui des décisions de santé publique. |w(CaOODSP)9.888432
85640|qPDF|s977 KB|uhttps://publications.gc.ca/collections/collection_2021/aspc-phac/HP40-269-2020-eng.pdf